All Episodes
Talking Techniques — 64 episodes
The BRAIN miniseries | Exploring the neuropathogenesis of HIV and mentoring the next generation of scientists
The BRAIN miniseries | Investigating the link between vascular health and neurodegeneration in underrepresented populations
The BRAIN miniseries | Meet the neuroengineer building brain-monitoring devices and thriving communities
Cytokine networks in autoimmune diseases: mechanisms, pathogenesis and therapeutic innovations
Skills-based teaching and microcredentialing in STEM
Antigen validation and T-cell receptor engineering for cancer immunotherapies
Cytokines: from therapeutics to diagnostics
Spatial analysis of the immune-cell-surface proteome at a single-cell resolution
Investigating the neurological pathways underlying vocal communication
Rare disease and pharmacogenomics
One man’s waste in another man’s treasure: using wastewater to monitor infectious diseases
Next-generation antibody therapeutics
Investigating resistant leukemia with single-cell technologies
CAR-T and CAR-NK cell therapies
Mitochondria, the immune system and cancer: discovering new insights with spatial technologies
Long-read sequencing, metagenomics and the microbiome
Open neuroscience and the meaning of FAIR
Welcome to the jungle: sequencing for conservation
Neuropixels: big data heaven or burying the lead in averages?
Microbiome profiling techniques: from immunology to agriculture
The gut–brain axis and addiction
3D cell cultures: the latest developments, applications and regulations in the field
rAAVs, host-cell contamination and ddPCR
HPV, epigenetics and cancer: sequencing for new insights and to correct healthcare inequality
Artificial intelligence in healthcare
Liquid biopsy and cfNAs: driving forward diagnostics and disease research
The evolution of recombinant antibodies
The epigenetic clock
Resolving spatial biology in neuroscience
Introducing STEM Tea
Cell proliferation in drug screening
Synthetic biology: from cancer to the climate crisis
Establishing an epigenetic lens to explore cancer and infectious diseases
Target enrichment for NGS: why, how and what's next?
Producing challenging proteins in the golden age of protein engineering
The evolution of PCR: From q to dd and beyond
Molecular therapeutics: how far have we come and what's on the horizon?
Adeno-associated viral therapies: harnessing the power of HPLC
Organoids: advancing drug discovery and cancer research
The ethics of whole-genome sequencing: from race and religion to science fiction
Revitalizing the western blot
From space to the streets: infectious disease sampling in extreme conditions and extraordinary circumstances
Revealing the regulome: using multiomic approaches to explore epigenetics and DNA expression
The oncolytic Trojan horse: Immune cells, the tumor microenvironment and the invasion of neurons
Whole-genome-sequencing: navigating the "Diagnostic Odyssey" in rare disease research
The wonders of wastewater surveillance for COVID-19
How PCR has prevailed during the COVID-19 pandemic
Reproducibility in microbiomics
How can we achieve gender equality in STEM?
COG-UK: sequencing SARS-CoV-2 and detecting the novel variant B.1.1.7
COVID-19 diagnostics: which test should you choose?
Andy Tay: Forbes, awards and championing diversity in STEM
How has neuroimaging continued and flourished during the COVID-19 pandemic?
The reproducibility crisis: where are we now and how can we progress?
CRISPR: developing an equitable technology amidst a global pandemic
Helicopter research and the challenges and misconceptions of research in Africa
Big data and COVID-19 part 2: Affecting policy and revealing risk
Big data and COVID-19 part 1: Facilitating and using collaborative, open data
DNA vaccines: combating cancer and COVID-19
The sustainable lab: energy efficiency, glass vs plastic and human behavior
UV LEDs for disinfection and potential protection from SARS-CoV-2
Rob Vries on organoids for drug discovery and the study of COVID-19
Donald Ingber: How COVID-19 is changing conservatism in life sciences
Donald Ingber on COVID-19, organ-on-a-chip technology and the Wyss Institute